Optimal imaging sequence for staging in colorectal liver metastases: Analysis of three hypothetical imaging strategies

European Journal of Cancer

Volumn 50, Issue 5, 2014, Pages 937-943

  Yip, Vincent S ^a   Collins, Brendan ^b   Dunne, Declan F J ^a   Koay, Mei Y ^a   Tang, Joseph M ^a   Wieshmann, Hulya ^a   Fenwick, Stephen W ^a   Poston, Graeme J ^a   Malik, Hassan Z ^a  

^a UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL MANAGEMENT SCHOOL   (United Kingdom)

Author keywords

Colorectal liver metastases; Cost analysis; PET CT; Radiology

Indexed keywords

ARTICLE; CANCER STAGING; COHORT ANALYSIS; COLORECTAL LIVER METASTASIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HEALTH CARE COST; HUMAN; LIVER DISEASE; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

COLORECTAL LIVER METASTASES; COST ANALYSIS; PET-CT; RADIOLOGY;

COLORECTAL NEOPLASMS; DIAGNOSTIC IMAGING; FEMALE; HUMANS; INTERDISCIPLINARY COMMUNICATION; LIVER; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84896723892     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2013.11.025     Document Type: Article

References (20)

1. NICE. Colorectal cancer: the diagnosis and management of colorectal cancer. 2011.
2. T.J. Ruers, B. Wiering, and J.R. van der Sijp et al. Improved selection of patients for hepatic surgery of colorectal liver metastases with (18)F-FDG PET: a randomized study J Nucl Med 50 7 2009 July 1036 1041
3. E.A. Zerhouni, C. Rutter, and S.R. Hamilton et al. CT and MR imaging in the staging of colorectal carcinoma: report of the Radiology Diagnostic Oncology Group II Radiology 200 2 1996 August 443 451
4. D.F. Dunne, J. Gaughran, and R.P. Jones et al. Routine staging laparoscopy has no place in the management of colorectal liver metastases Eur J Surg Oncol 39 7 2013 July 721 725
5. R.P. Jones, J.N. Vauthey, and R. Adam et al. Effect of specialist decision-making on treatment strategies for colorectal liver metastases Br J Surg 99 9 2012 September 1263 1269
6. R.P. Jones, H.Z. Malik, S.W. Fenwick, and G.J. Poston Perioperative chemotherapy for resectable colorectal liver metastases: Where now? Eur J Surg Oncol 2013 May 29
7. G.J. Poston, D. Tait, S. O'Connell, A. Bennett, and S. Berendse Diagnosis and management of colorectal cancer: summary of NICE guidance BMJ 343 2011 d6751
8. H. Singh, E. Shu, A. Demers, C.N. Bernstein, J. Griffith, and K. Fradette Trends in time to diagnosis of colon cancer and impact on clinical outcomes Can J Gastroenterol 26 12 2012 December 877 880
9. Informatics SH. Somerset Cancer Register. Somerset HIS; 2009. p. Somerset Cancer Register.
10. R. Boellaard, M.J. O'Doherty, and W.A. Weber et al. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0 Eur J Nucl Med Mol Imaging 37 1 2010 January 181 200
11. Y. Fong, J. Fortner, R.L. Sun, M.F. Brennan, and L.H. Blumgart Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases Ann Surg 230 3 1999 September 309 318 (discussion 18-21)
12. P.A. Clavien, J. Barkun, and M.L. de Oliveira et al. The Clavien-Dindo classification of surgical complications: five-year experience Ann Surg 250 2 2009 August 187 196
13. A. Ivanecz, S. Potrc, M. Horvat, T. Jagric, and E. Gadzijev The validity of clinical risk score for patients undergoing liver resection for colorectal metastases Hepatogastroenterology 56(94-95) 2009 September-October 1452 1458
14. S.J. Shin, J.B. Ahn, and J.S. Choi et al. Implications of clinical risk score to predict outcomes of liver-confined metastasis of colorectal cancer Surg Oncol 21 3 2012 September e125 e130
15. M. Rees, P.P. Tekkis, F.K. Welsh, T. O'Rourke, and T.G. John Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients Ann Surg 247 1 2008 January 125 135
16. F.K. Welsh, P.P. Tekkis, T. O'Rourke, T.G. John, and M. Rees Quantification of risk of a positive (R1) resection margin following hepatic resection for metastatic colorectal cancer: an aid to clinical decision-making Surg Oncol 17 1 2008 July 3 13
17. C. Lejeune, M.J. Bismuth, and T. Conroy et al. Use of a decision analysis model to assess the cost-effectiveness of 18F-FDG PET in the management of metachronous liver metastases of colorectal cancer J Nucl Med 46 12 2005 Decembe 2020 2028
18. B. Nordlinger, H. Sorbye, and B. Glimelius et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial Lancet 371 9617 2008 March 22 1007 1016
19. B. Wiering, E.M. Adang, and J.R. van der Sijp et al. Added value of positron emission tomography imaging in the surgical treatment of colorectal liver metastases Nucl Med Commun 31 11 2010 November 938 944
20. G. Ercolani, A. Cucchetti, and M. Cescon et al. Effectiveness and cost-effectiveness of peri-operative versus post-operative chemotherapy for resectable colorectal liver metastases Eur J Cancer 47 15 2011 October 2291 2298